Efecto de las terapias incretínicas comparadas con pioglitazona y gliclazida en la esteatosis hepática no alcohólica de los pacientes diabéticos no controlados solo con metformina: estudio observacional piloto-Reference-Cited by-同舟云学术

Efecto de las terapias incretínicas comparadas con pioglitazona y gliclazida en la esteatosis hepática no alcohólica de los pacientes diabéticos no controlados solo con metformina: estudio observacional piloto

Published:2016-05 Issue:5 Volume:63 Page:194-201
ISSN:1575-0922
Container-title:Endocrinología y Nutrición
language:es
Short-container-title:Endocrinología y Nutrición

Author:

García Díaz Eduardo,Guagnozzi Danila,Gutiérrez Verónica,Mendoza Carmen,Maza Cristina,Larrañaga Yulene,Perdomo Dolores,Godoy Teresa,Taleb Ghalli

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference30 articles.

1. Prevalence and associated factors in non alcoholic fatty liver disease in patients with type 2 diabetes mellitus;Leite;Liver Int.,2009

2. Increased overall mortality and liver related mortality in non-alcoholic fatty liver disease;Ong;J Hepatol.,2008

3. Non-alcoholic fatty liver disease: Epidemiology, clinical course, investigation, and treatment;Weiß;Dtsch Arztebl Int.,2014

4. Non-alcoholic fatty liver disease: Current concepts and management strategies;Day;Clin Med (Lond).,2006

5. Nonalcoholic fatty liver disease: A review of current understanding and future impact;Charlton;Clin Gastroenterol Hepatol.,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the treatment of hepatogenous diabetes: A review;Medicine;2023-11-17

2. Metformin induces pyroptosis in leptin receptor-defective hepatocytes via overactivation of the AMPK axis;Cell Death & Disease;2023-02-03

3. A randomized triple-blind controlled clinical trial evaluation of sitagliptin in the treatment of patients with non-alcoholic fatty liver diseases without diabetes;Frontiers in Medicine;2022-07-28

4. Metabolic Syndrome and Metabolic Dysfunction‐Associated Fatty Liver Disease;Clinical Obesity in Adults and Children;2022-03-11

5. Liraglutide in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials;Clinics and Research in Hepatology and Gastroenterology;2021-05